Drug details

Tezspire (tezepelumab-ekko injection, for subcutaneous use)

type of Monoclonal Antibodies, Anti-asthmatics

Tezspire (tezepelumab-ekko) is a thymic stromal lymphopoietin (TSLP) blocker, human monoclonal antibody (IgG2λ), indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma

The drug is often used to treat Asthma .

This drug may have the following side effects:

• rash, and
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• severe dizziness, 
• red, irritated, or itchy eyes

The following drugs are related to Tezspire, either as a replacement or used together:

• Anoro Ellipta (umeclidinium and vilanterol inhalation powder)
• Arnuity Ellipta (fluticasone furoate inhalation powder)
• Atrovent HFA (ipratropium bromide inhalation aerosol)
• Fasenra (benralizumab for subcutaneous injection)
• Bevespi Aerosphere (glycopyrrolate and formoterol fumarate inhalation aerosol)
• Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
• Eucrisa Ointment (crisaborole)
• Dupixent (dupilumab injection)
• Trelegy Ellipta (fluticasone furoate inhalation powder)
• Wixela Inhub (fluticasone propionate and salmeterol inhalation powder)
• Incruse Ellipta (umeclidinium inhalation powder)
• Xolair (omalizumab)
• Stiolto Respimat (tiotropium bromide and olodaterol)